Current up-front therapeutic approaches for classic Hodgkin lymphoma (cHL) in children and young adults aim to reduce treatment intensity to minimize long-term treatment-related morbidity. This strategy assumes that patients who relapse can still achieve durable remission with a combination of…
2025 is here and medicine has continued to move away from the utopian vision of our admission essays for medical school. We are spending countless…
Presenter: Elizabeth Nally, BSc, MBBS Presenter: Atulya Aman Khosla, MD, MBBS Presenter: Annalis a Guida, MD Presenter: Alan Pollack, MD, PhD Presenter: Sean Ryan Miller,…
There is little that matters more to populations than their health. This has long made health a central concern for governments and policymakers worldwide, a…
Platform fosters collegial interactions among scientists, but potentially limits interactions beyond the academic community
A 46-year-old woman is referred for a second opinion with recent onset of suspected seizures and imbalance. Fundus examination revealed bilateral discrete perifoveal circular areas…
This cross-sectional study evaluates the approval status and timeline and therapeutic value of urgently needed overseas drugs in China.
This cohort study evaluates the survival outcomes of currently smoking patients with cancer who entered into a smoking cessation treatment program based on the time…
This cohort study examines the association of treatment with metformin and add-on antidiabetic medications with asthma attacks.
Adding inotuzumab ozogamicin (InO) to hyper-CVAD and blinatumomab may improve outcomes in newly diagnosed Philadelphia chromosome (Ph)-negative B-cell acute lymphoblastic leukemia (B-ALL). Patients w…
Listen now | A conversation with Margaret McCartney
